Today: 4 February 2026
Subscribe
Browse Category

NASDAQ:AVXL News 12 December 2025

Anavex Life Sciences (AVXL) Stock Drops After EMA Recommends Refusal of Blarcamesine: Latest News, Analyst Forecasts, and What’s Next (Dec. 12, 2025)

Anavex Life Sciences (AVXL) Stock Drops After EMA Recommends Refusal of Blarcamesine: Latest News, Analyst Forecasts, and What’s Next (Dec. 12, 2025)

Anavex Life Sciences Corp. (NASDAQ: AVXL) is back in the spotlight on Friday, December 12, 2025, after European regulators recommended refusing marketing authorization for Blarcamesine Anavex (also known as blarcamesine / ANAVEX®2-73) in Alzheimer’s disease—an outcome that investors had been bracing for since last month’s negative “trend vote” from the EMA’s scientific committee. European Medicines Agency (EMA) The regulatory news…
12 December 2025
·····

Stock Market Today

  • First Majestic Silver Completes Gatos Deal, Boosts Production and Dividend at CA$30 Share Price
    February 3, 2026, 10:42 PM EST. First Majestic Silver (TSX:AG) has finalized its acquisition of Gatos Silver, significantly increasing its silver production capacity and generating record output. The deal strengthens its cash flow, prompting management to announce a dividend increase. The stock has surged 242% over the past year to around CA$30.08, reflecting strong investor response despite a recent 13.9% pullback. Analysts price the shares near fair value with a consensus target of CA$34.00. Investors should monitor ongoing production results, cash flow, and the potential for further capital allocation shifts as the company integrates Gatos Silver. Concerns remain over shareholder dilution due to recent equity issuance. The transaction reshapes First Majestic's investment case amid firm market momentum.
Go toTop